
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
C4 glomerulopathy pathophysiology
Introduction
Overview
Overview
It is thought that C4 glomerulopathy is the result of the activation of immune complex glomerulonephritis or lectin pathway of the complement.
Pathophysiology
Pathophysiology
- The generation of the classical pathway of complement occurs by the immune complex.
- Immune complex glomerulonephritis, such as lupus, frequently activates the classical pathway by binding C1q to the antibody-containing immune complexes, which can result in glomerular deposition of immunoglobulins, C3, C1q, and C4d.
- C4 activation can also ensue by the lectin pathway of complement.
- In the lectin pathway, mannose-binding lectins bind to mannose located on the carbohydrates structure or microbial membranes, which activate C4 (and therefore bypass C1q), resulting in the formation of the classical pathway C3 convertase.
- Glomerular C4d, is a split creation of C4, is suggestive of C4 activation as a result of activation of either the lectin pathway of the classical complement pathway.
- In C4 glomerulopathy, bright streak for C4d indicates mesangial/capillary wall deposits. C4d deposits are present in a few cases of IgA nephropathy and post-streptococcal glomerulonephritis[1][2][3][4][5].
References
References
- ↑ Sethi S, Nasr SH, De Vriese AS, Fervenza FC (2015). “C4d as a Diagnostic Tool in Proliferative GN”. J Am Soc Nephrol. 26 (11): 2852–9. doi:10.1681/ASN.2014040406. PMC 4625660. PMID 25991041.
- ↑ Larsen CP, Messias NC, Walker PD, Fidler ME, Cornell LD, Hernandez LH; et al. (2015). “Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits”. Kidney Int. 88 (4): 867–73. doi:10.1038/ki.2015.195. PMC 4687465. PMID 26154922.
- ↑ Weening JJ, D’Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB; et al. (2004). “The classification of glomerulonephritis in systemic lupus erythematosus revisited”. J Am Soc Nephrol. 15 (2): 241–50. doi:10.1097/01.asn.0000108969.21691.5d. PMID 14747370.
- ↑ Batal I, Liang K, Bastacky S, Kiss LP, McHale T, Wilson NL; et al. (2012). “Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study”. Lupus. 21 (1): 13–26. doi:10.1177/0961203311422093. PMID 21959138.
- ↑ Espinosa M, Ortega R, Sánchez M, Segarra A, Salcedo MT, González F; et al. (2014). “Association of C4d deposition with clinical outcomes in IgA nephropathy”. Clin J Am Soc Nephrol. 9 (5): 897–904. doi:10.2215/CJN.09710913. PMC 4011455. PMID 24578331.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
